Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research.

European geriatric medicine·2021
Same author

Detection of medications associated with Alzheimer's disease using ensemble methods and cooperative game theory.

International journal of medical informatics·2020
Same author

Personality disorders of drivers killed in fatal motor vehicle accidents in Finland during 1990-2011.

Acta psychiatrica Scandinavica·2019
Same author

Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research.

Drugs & aging·2019
Same author

Editorial: let's take a break from studying the PPI-fracture association-Authors' reply.

Alimentary pharmacology & therapeutics·2018

Related Experiment Video

Updated: Jul 9, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Smoking makes asthma expensive: a register-based study in Finland.

P Ikäheimo1, T Tuuponen, J Kiuttu

  • 1Department of Public Health Science and General Practice, University of Oulu, Oulu, Finland. pekka.ikaheimo@oulu.fi

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|November 24, 2007
PubMed
Summary

Smoking-related chronic obstructive pulmonary disease (COPD) significantly increases healthcare costs for asthma patients. Quitting smoking is crucial for managing asthma comorbidities and reducing expenses.

More Related Videos

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

Related Experiment Videos

Last Updated: Jul 9, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

Area of Science:

  • Pulmonary Medicine
  • Health Services Research

Background:

  • Asthma patients, particularly smokers, frequently develop chronic bronchitis and chronic obstructive pulmonary disease (COPD)/emphysema.
  • This comorbidity significantly impacts healthcare resource utilization and associated costs.

Purpose of the Study:

  • To quantify the increased use of health services and costs in asthma patients with comorbid COPD/emphysema compared to those with asthma alone.
  • To assess the financial burden of these comorbidities on healthcare systems.

Main Methods:

  • A cohort of 3160 adult asthma patients aged 40 years and older was analyzed.
  • Data on comorbidity, healthcare utilization, and medication expenses were collected via questionnaires and national prescription registers.

Main Results:

  • Asthma patients with COPD/emphysema (12% of the cohort) incurred 21% of doctor consultations and 39% of inpatient days.
  • These patients accounted for 27% of total expenses, with mean annual costs of €2107 compared to €754 for asthma-only patients.
  • Current smoking further escalated costs among patients with concurrent COPD/emphysema.

Conclusions:

  • Pulmonary comorbidity in asthma patients leads to substantially higher healthcare costs.
  • Integrating smoking cessation programs into asthma management is essential for preventing comorbidity and reducing healthcare expenditure.